Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 3Suspended 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 6Breast Neoplasms 5Neoplasms 4Colorectal Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Glioma 3Solid Tumors 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Melanoma 2Brain Neoplasms 2Astrocytoma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Testicular Neoplasms 1Solid Tumor 1Primary Myelofibrosis 1Polycythemia Vera 1Papillomavirus Infections 1Pancreatic Ductal Adenocarcinoma 1PTEN Gene Mutation 1Ovarian Neoplasms 1Neuroma, Acoustic 1Neuroma 1

Interventions

Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Neuroma × 30 days × Clear all
NCT01083966 2026-06-01

Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma

Northwell Health

Phase 1 Suspended
30 enrolled
CNS

Brain Neoplasms, Neurilemmoma, Neuroma, Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡